Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | proteasome subunit beta type 1 | 0.0064 | 0.0678 | 0.0678 |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.0123 | 0.2318 | 1 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.0123 | 0.2318 | 1 |
Brugia malayi | Trypsin family protein | 0.0077 | 0.1027 | 0.1027 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.1215 | 0.1215 |
Brugia malayi | Fibulin-1 precursor | 0.0065 | 0.0686 | 0.0686 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0083 | 0.1197 | 0.1197 |
Schistosoma mansoni | aminopeptidase PILS (M01 family) | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0123 | 0.2318 | 0.1759 |
Toxoplasma gondii | PAN domain-containing protein | 0.0373 | 0.9372 | 1 |
Onchocerca volvulus | 0.0077 | 0.1027 | 0.1027 | |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0686 | 0.0686 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0083 | 0.1197 | 0.9669 |
Brugia malayi | Kringle domain containing protein | 0.0083 | 0.1215 | 0.1215 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0083 | 0.1197 | 1 |
Echinococcus multilocularis | fibrillin 1 | 0.0065 | 0.0686 | 0.0045 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0083 | 0.1197 | 0.5 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Echinococcus multilocularis | subfamily S1A unassigned peptidase (S01 family) | 0.0077 | 0.1027 | 0.2127 |
Echinococcus multilocularis | laminin | 0.0065 | 0.0686 | 0.0045 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0083 | 0.1197 | 0.5 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Echinococcus granulosus | Tolloid protein 1 | 0.0065 | 0.0686 | 0.0045 |
Leishmania major | hypothetical protein, conserved | 0.0083 | 0.1215 | 1 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0083 | 0.1197 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0083 | 0.1197 | 1 |
Echinococcus multilocularis | enteropeptidase | 0.0123 | 0.2318 | 1 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0074 | 0.0958 | 0.1707 |
Echinococcus granulosus | proteasome prosome macropain | 0.0083 | 0.1197 | 0.3164 |
Onchocerca volvulus | 0.0077 | 0.1027 | 0.1027 | |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.0065 | 0.0686 | 0.0686 |
Toxoplasma gondii | kringle domain-containing protein | 0.0083 | 0.1215 | 0.1296 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0686 | 0.0686 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0083 | 0.1215 | 0.1215 |
Brugia malayi | hypothetical protein | 0.0077 | 0.1027 | 0.1027 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0083 | 0.1197 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0083 | 0.1215 | 0.1215 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1027 | 0.1027 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0083 | 0.1197 | 0.1277 |
Echinococcus granulosus | Mastin | 0.0123 | 0.2318 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0083 | 0.1215 | 0.0576 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1027 | 0.1027 |
Onchocerca volvulus | 0.0396 | 1 | 1 | |
Toxoplasma gondii | PAN domain-containing protein | 0.0373 | 0.9372 | 1 |
Toxoplasma gondii | proteasome subunit beta type 1, putative | 0.0064 | 0.0678 | 0.0724 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Echinococcus granulosus | laminin | 0.0065 | 0.0686 | 0.0045 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0686 | 0.0686 |
Onchocerca volvulus | 0.0077 | 0.1027 | 0.1027 | |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0396 | 1 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0083 | 0.1215 | 0.3272 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1027 | 0.1027 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0083 | 0.1197 | 0.1197 |
Brugia malayi | Trypsin family protein | 0.0077 | 0.1027 | 0.1027 |
Loa Loa (eye worm) | trypsin family protein | 0.0077 | 0.1027 | 0.1027 |
Echinococcus granulosus | transmembrane protease serine 3 | 0.0077 | 0.1027 | 0.2127 |
Echinococcus multilocularis | Peptidase S1 S6, chymotrypsin Hap | 0.0077 | 0.1027 | 0.2127 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0065 | 0.0686 | 0.0008 |
Echinococcus granulosus | subfamily S1A unassigned peptidase S01 family | 0.0077 | 0.1027 | 0.2127 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1027 | 0.1027 |
Onchocerca volvulus | Arrow homolog | 0.0065 | 0.0686 | 0.0686 |
Brugia malayi | Trypsin family protein | 0.0077 | 0.1027 | 0.1027 |
Brugia malayi | Trypsin-like protease protein 5 | 0.0077 | 0.1027 | 0.1027 |
Echinococcus multilocularis | transmembrane protease serine 3 | 0.0077 | 0.1027 | 0.2127 |
Onchocerca volvulus | 0.0077 | 0.1027 | 0.1027 | |
Echinococcus granulosus | enteropeptidase | 0.0123 | 0.2318 | 1 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0396 | 1 | 1 |
Brugia malayi | Chymotrypsin-like protease CTRL-1 precursor | 0.0077 | 0.1027 | 0.1027 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.0065 | 0.0686 | 0.0686 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0083 | 0.1215 | 0.3272 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0065 | 0.0686 | 0.0732 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0083 | 0.1215 | 1 |
Loa Loa (eye worm) | proteasome subunit beta type 1 | 0.0064 | 0.0678 | 0.0678 |
Echinococcus multilocularis | Mastin | 0.0123 | 0.2318 | 1 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0083 | 0.1197 | 0.9669 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0686 | 0.0686 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0074 | 0.0958 | 0.1707 |
Mycobacterium ulcerans | proteasome PrcB | 0.0083 | 0.1197 | 1 |
Echinococcus granulosus | Peptidase S1 S6 chymotrypsin Hap | 0.0077 | 0.1027 | 0.2127 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0686 | 0.0686 |
Onchocerca volvulus | 0.0083 | 0.1215 | 0.1215 | |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0065 | 0.0686 | 0.0686 |
Schistosoma mansoni | hypothetical protein | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0065 | 0.0686 | 0.0686 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0065 | 0.0686 | 0.0732 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0083 | 0.1197 | 0.3164 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0083 | 0.1197 | 0.0556 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0083 | 0.1215 | 1 |
Onchocerca volvulus | 0.0319 | 0.7845 | 0.7845 | |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0083 | 0.1197 | 0.9669 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0083 | 0.1215 | 1 |
Schistosoma mansoni | egf-like domain protein | 0.0065 | 0.0686 | 0.0008 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0065 | 0.0686 | 0.0045 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0083 | 0.1197 | 0.9669 |
Schistosoma mansoni | cercarial elastase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0077 | 0.1027 | 0.0374 |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.0065 | 0.0686 | 0.0686 |
Onchocerca volvulus | 0.0077 | 0.1027 | 0.1027 | |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1027 | 0.1027 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0083 | 0.1197 | 0.9669 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
2aPTT (functional) | = 6.1 uM | Activity in human plasma by aPTT assay | ChEMBL. | 16682200 |
2aPTT (functional) | = 6.1 uM | Anticoagulant activity in human plasma measured as activated partial thromboplastin time | ChEMBL. | 16870435 |
2PT (functional) | = 1.9 uM | Activity in rabbit plasma by PT assay | ChEMBL. | 16682200 |
2PT (functional) | = 1.9 uM | Anticoagulant activity in rabbit plasma measured as prothrombin time | ChEMBL. | 16870435 |
2PT (functional) | = 2.1 uM | Activity in human plasma by PT assay | ChEMBL. | 16682200 |
2PT (functional) | = 2.1 uM | Anticoagulant activity in human plasma measured as prothrombin time | ChEMBL. | 16870435 |
Activity (functional) | = 1.9 uM | Anticoagulant activity in human plasma assessed as concentration required to double prothrombin time | ChEMBL. | 17588746 |
aPTT (functional) | = 6.1 uM | Activated partial thromboplastin time was determined in the human plasma | ChEMBL. | 15771420 |
Binding (ADMET) | = 90.5 % | Binding affinity of the compound against human plasma protein was determined | ChEMBL. | 15771420 |
Binding (ADMET) | = 93.4 % | Binding affinity of compound was determined against rabbit plasma protein | ChEMBL. | 15771420 |
Cl (ADMET) | = 1.1 l hr-1 kg-1 | Clearance of the compound in dogs upon 0.4 mg/kg intravenous administration | ChEMBL. | 15771420 |
CL (ADMET) | = 1.1 L/hr.Kg | Clearance in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16682200 |
CL (ADMET) | = 1.1 L/hr.Kg | Clearance in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16870435 |
F (ADMET) | = 84 % | Oral bioavailability of compound was determined in dogs upon 0.2 mg/kg administration | ChEMBL. | 15771420 |
F (ADMET) | = 84 % | Oral bioavailability in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16682200 |
F (ADMET) | = 84 % | Bioavailability in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16870435 |
IC50 (functional) | = 340 nM | Inhibition of thrombus formation in iv dosed rabbit arterio-venous shunt model | ChEMBL. | 16682200 |
IC50 (functional) | = 340 nM | Inhibition of thrombus formation in iv dosed rabbit arterio-venous shunt model | ChEMBL. | 16870435 |
ID50 (functional) | = 1.6 umol/kg/h | Inhibitory dose against thrombus formation in rabbit arterio-venous shunt thrombosis model upon intravenous administration | ChEMBL. | 15771420 |
ID50 (functional) | = 1.6 umol/kg/hr | Inhibition of thrombus formation in iv dosed rabbit arterio-venous shunt model | ChEMBL. | 16682200 |
ID50 (functional) | = 1.6 umol/kg/hr | Inhibition of thrombus formation in iv dosed rabbit arterio-venous shunt model | ChEMBL. | 16870435 |
Ki (binding) | = 0.16 nM | Binding affinity determined against rabbit Coagulation factor Xa | ChEMBL. | 15771420 |
Ki (binding) | = 0.19 nM | Binding affinity against human Coagulation factor Xa | ChEMBL. | 15771420 |
Ki (binding) | = 0.19 nM | Binding affinity against blood clotting factor X | ChEMBL. | 15771420 |
Ki (binding) | = 0.19 nM | Binding affinity to rabbit f10a | ChEMBL. | 16682200 |
Ki (binding) | = 0.19 nM | Binding affinity to human f10a | ChEMBL. | 16682200 |
Ki (binding) | = 0.19 nM | Binding affinity to human f10a | ChEMBL. | 16870435 |
Ki (binding) | = 0.19 nM | Binding affinity to rabbit f10a | ChEMBL. | 16870435 |
Ki (binding) | = 0.19 nM | Inhibition of human factor 10a | ChEMBL. | 17588746 |
Ki (binding) | = 540 nM | Binding affinity against human thrombin | ChEMBL. | 15771420 |
Ki (binding) | = 540 nM | Binding affinity to thrombin | ChEMBL. | 16682200 |
Ki (binding) | = 540 nM | Binding affinity to human thrombin | ChEMBL. | 16870435 |
Ki (binding) | = 600 nM | Binding affinity against human thrombin | ChEMBL. | 15771420 |
Ki (binding) | > 2300 nM | Binding affinity determined against human kallikrein | ChEMBL. | 15771420 |
Ki (binding) | = 8500 nM | Binding affinity against chymotrysin | ChEMBL. | 15771420 |
Ki (binding) | = 8500 nM | Binding affinity to chymotrypsin | ChEMBL. | 16682200 |
Ki (binding) | = 8500 nM | Binding affinity to human chymotrypsin | ChEMBL. | 16870435 |
Ki (binding) | = 9000 nM | Binding affinity against human Coagulation factor IX | ChEMBL. | 15771420 |
Ki (binding) | = 9000 nM | Binding affinity to f9a | ChEMBL. | 16682200 |
Ki (binding) | = 9000 nM | Binding affinity to human f9a | ChEMBL. | 16870435 |
Ki (binding) | > 10000 nM | Binding affinity determined against human trypsin | ChEMBL. | 15771420 |
Ki (binding) | > 10000 nM | Binding affinity to trypsin | ChEMBL. | 16682200 |
Ki (binding) | > 10000 nM | Binding affinity to human trypsin | ChEMBL. | 16870435 |
Ki (binding) | > 12000 nM | Binding affinity determined against coagulation factor XI | ChEMBL. | 15771420 |
Ki (binding) | > 13000 nM | Binding affinity determined against human urokinase | ChEMBL. | 15771420 |
Ki (binding) | > 13000 nM | Binding affinity to urokinase | ChEMBL. | 16682200 |
Ki (binding) | > 13000 nM | Binding affinity to human urokinase | ChEMBL. | 16870435 |
Ki (binding) | > 15000 nM | Binding affinity against human plasmin | ChEMBL. | 15771420 |
Ki (binding) | > 15000 nM | Binding affinity against coagulation factor VIIa | ChEMBL. | 15771420 |
Ki (binding) | > 15000 nM | Binding affinity to plasmin | ChEMBL. | 16682200 |
Ki (binding) | > 15000 nM | Binding affinity to f7a | ChEMBL. | 16682200 |
Ki (binding) | > 15000 nM | Binding affinity to human plasmin | ChEMBL. | 16870435 |
Ki (binding) | = 19700 nM | Binding affinity determined against human activated protein C | ChEMBL. | 15771420 |
Ki (binding) | = 19700 nM | Binding affinity to aPC | ChEMBL. | 16682200 |
Ki (binding) | = 19700 nM | Binding affinity to human activated protein C | ChEMBL. | 16870435 |
Ki (binding) | > 33000 nM | Binding affinity determined against tissue plasminogen activator | ChEMBL. | 15771420 |
Ki (binding) | > 33000 nM | Binding affinity to tPA | ChEMBL. | 16682200 |
Ki (binding) | > 33000 nM | Binding affinity to human tPA | ChEMBL. | 16870435 |
Papp (ADMET) | = 5.6 ucm/s | Apparent permeability in Caco2 cells | ChEMBL. | 16682200 |
Papp (ADMET) | = 5.6 ucm/s | Apparent permeability in Caco2 cells | ChEMBL. | 16870435 |
Permeability (functional) | = 0.00000556 cm s-1 | Apparent permeability of the compound was determined in Caco-2 (dog carcinoma) cells | ChEMBL. | 15771420 |
Permeability (functional) | = 5.56 cm s-1 | Apparent cell permeability of the compound was determined in Caco-2 cell line | ChEMBL. | 15771420 |
PPB (ADMET) | = 93 % | Protein binding in rabbit | ChEMBL. | 16682200 |
PPB (ADMET) | = 93 % | Protein binding in rabbit plasma | ChEMBL. | 16870435 |
T1/2 (ADMET) | = 3.4 hr | Half life of the compound in dogs upon 0.4 mg/kg intravenous administration | ChEMBL. | 15771420 |
T1/2 (ADMET) | = 3.4 hr | Half life in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16682200 |
T1/2 (ADMET) | = 3.4 hr | Half life in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16870435 |
Vdss (ADMET) | = 5.3 l kg-1 | Steady state volume of distribution in dogs upon 0.4 mg/kg intravenous administration | ChEMBL. | 15771420 |
Vdss (ADMET) | = 5.3 L/Kg | Volume of distribution in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16682200 |
Vdss (ADMET) | = 5.3 L/Kg | Volume of distribution in dog at 0.5 mg/kg, iv and 0.2 mg/kg, po | ChEMBL. | 16870435 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.